|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02563 BIOSTAR PHARM-B
Nominal 
3.860 0.000 (0.000%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 163,724 | 122,710 | 102,902 |
| Land & other Lease Assets | -- | -- | 13,556 | 13,477 | 14,862 |
| Intangible Assets | -- | -- | 752 | 1,627 | 2,832 |
| Interests in Asso. & JCEs | -- | -- | 0 | 0 | 0 |
| Other Non-current Assets | -- | -- | 35,953 | 1,000 | 1,072 |
| -- | -- | 213,985 | 138,814 | 121,668 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | -- | -- | 31,419 | 27,267 | 31,109 | |
| Trade Receivables | -- | -- | 23,152 | 11,159 | 34,620 | |
| Cash & Bank Balances | -- | -- | 189,714 | 38,087 | 60,106 | |
| Other Current Assets | -- | -- | 454,973 | 557,017 | 678,835 | |
| Assets Held for Sale | -- | -- | 0 | 0 | 0 | |
| -- | -- | 699,258 | 633,530 | 804,670 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 48,331 | 24,440 | 20,099 | ||
| S-T Debt & Leases | -- | -- | 665 | 732 | 1,091 | ||
| Other Current Liabilities | -- | -- | 30,165 | 18,571 | 30,535 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | ||
| -- | -- | 79,161 | 43,743 | 51,725 | |||
| Net Current Assets | -- | -- | 620,097 | 589,787 | 752,945 | ||
| Total Assets Less Current Liabilities | -- | -- | 834,082 | 728,601 | 874,613 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 517 | 167 | 813 | |||
| Other Non-current Liabilities | -- | -- | 42,819 | 5,273 | 5,875 | |||
| -- | -- | 43,336 | 5,440 | 6,688 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 364,588 | 350,000 | 350,000 | ||||
| Reserves | -- | -- | 426,158 | 373,161 | 517,925 | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 790,746 | 723,161 | 867,925 | ||||
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| -- | -- | 790,746 | 723,161 | 867,925 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 65,260 | 108,402 | 136,242 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -131,435 |
| %Change | -8.583% |
| EPS / (LPS) | RMB -0.360 |
| NBV Per Share (¥) | RMB -- |